Getty Images

Q and A with the experts: AstraZeneca and viral vector vaccines

Posted on

The AstraZeneca vaccine has recently been approved in Canada and is evaluated to be about 62 per cent effective in preventing the COVID-19 virus.

Kelly Grindrod, a pharmacist and professor, breaks down how this vaccine and others like it work.

https://uwaterloo.ca/news/media/q-and-experts-astrazeneca-and-viral-vector-vaccines

Read More Impact Stories

Posted on
For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Posted on
McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Posted on
Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]